Methyl 4-Bromo-1H-Pyrrole-2-Carboxylate

In medicinal chemistry discovery programs, methyl 4-bromo-1H-pyrrole-2-carboxylate serves as a densely functionalized heterocyclic template for constructing targeted kinase and GPCR screening libraries. The 4-position bromine atom undergoes palladium-catalysed Suzuki–Miyaura cross-coupling with arylboronic acids using Pd(PPh₃)₄ at 1.5 mol% loading, aqueous K₂CO₃ as base, and a degassed toluene/ethanol solvent mixture at 80 °C for 12 h. This process has been scaled across multiple batches in a 50 L jacketed glass-lined reactor with anchor stirrer operating at 180 rpm, while inline HPLC monitors conversion until residual starting ester area percentage falls below 0.5%. After quench, ethyl acetate extraction and silica gel plug purification deliver the biaryl intermediate; residual palladium is determined by ICP‑MS and must not exceed 10 ppm to satisfy the ICH Q3D limit for oral drug substances. The methyl ester group remains intact during cross-coupling and can be selectively cleaved in a subsequent step using LiOH in THF/water at 23 °C to liberate the free carboxylic acid, which is then available for amidation or protodeboronation. Long-term stability studies under nitrogen at 2–8 °C confirm >99.0% purity retention over 12 months when moisture is excluded (Karl Fischer water content < 0.1%). A notable operational boundary: extended exposure to pH >10 at temperatures above 40 °C promotes N–H deprotonation and slow ring decomposition, releasing bromide ion detectable by ion chromatography.

How Does Temperature Window Control 5-Position Lithiation Selectivity?

When a late-stage C5 functionalization sequence is required, direct lithiation–electrophile trapping offers regiochemical control that complements the bromine handle. In this regime the resident 4-bromine substituent creates a competing lithium–halogen exchange channel, so ultra-low thermal management determines the fate of the anion. A standard procedure charges the ester substrate into anhydrous THF (water content < 50 ppm by Karl Fischer) and cools the solution to −78 °C with a dry‑ice/acetone bath or a recirculating chiller. A 1.05 eq. portion of freshly titrated lithium diisopropylamide (2.0 M in THF/heptane/ethylbenzene) is introduced at 0.5 mL/min while the internal temperature is held within a ±3 °C band. Under this envelope, formation of the 5‑lithio species dominates; ReactIR monitoring detects a characteristic absorption shift near 1612 cm⁻¹ without evolution of the band assigned to debrominated pyrrole. Quenching with DMF (formylation) or tributyltin chloride at −78 °C yields the 5‑substituted product after aqueous work‑up. Data gathered during process safety evaluation showed that when the jacket temperature inadvertently drifted to −60 °C, the debromination by‑product fraction rose sharply from < 3% to 22–35% (HPLC area% at 254 nm), resulting in a 20–30% yield loss after column purification. This steep selectivity cliff dictates that pilot‑scale equipment must provide precise temperature control; the routine setup employs a Huber TC100 immersion cooler coupled with an internal Pt100 probe and cascade control logic. On 5 kg substrate input the heat‑transfer surface‑to‑volume ratio becomes the rate‑limiting factor, making a jacketed cylindrical vessel with a 3:1 aspect ratio preferable. The table below compares product distributions collected with different electrophile/temperature combinations; values reflect general trends documented for pyrrole‑2‑carboxylate analogues, while compound‑specific published data remain limited.

In crop protection research, the ester is deployed as an intermediate for pyrrole‑amide insecticides structurally related to anthranilic diamides. A frequently travelled path starts with direct ester aminolysis: the methyl ester is treated with 1.5 eq. of a primary amine in anhydrous THF containing catalytic 2‑hydroxypyridine (10 mol%), heated to 45 °C for 8 h, forming the corresponding pyrrole‑2‑carboxamide. The bromine at the 4‑position then enters a subsequent Suzuki coupling with a substituted phenylboronic acid, furnishing a lead‑generation library. Final products are filtered through a pad of silica and recrystallized from heptane/ethyl acetate; purity is verified by HPLC in accordance with CIPAC MT 46 and must read above 95 area%. Field‑trial material requires residual solvent analysis documented under EPA OPPTS 830.6300 guidelines, and the batch record enforces a post‑reaction pH adjustment ceiling of 10 at temperatures below 30 °C to suppress base‑catalysed decomposition of the brominated pyrrole ring. A production‑scale observation notes that the aminolysis step is acutely moisture‑sensitive; THF must be dried over sodium/benzophenone to a water specification of < 0.01% before charging, otherwise rampant ester hydrolysis depresses the amide yield below 60%. When scaling beyond 20 L glassware, the addition of the amine is best performed over 1.5 h with jacket cooling to counteract the mild exotherm (ΔT_ad ≈ 15 °C).

If the Ultimate Target is a Dipyrromethane for Porphyrinic Materials

Syntheses directed toward photodynamic therapy sensitizers or chemosensor porphyrins rely on dipyrromethane precursors that are conveniently assembled from the 4‑bromopyrrole‑2‑carboxylate scaffold. In a classic one‑flask condensation, 2.0 eq. of the pyrrole ester and 1.0 eq. of an aryl aldehyde (e.g., p‑tolualdehyde) are dissolved in CH₂Cl₂ and treated with boron trifluoride diethyl etherate (0.15 eq.) at 0–5 °C. After 30 min of stirring, triethylamine is added to quench the acid catalyst, and the resulting α,ω‑diene intermediate is immediately purified by gravity column chromatography (silica, hexane/ethyl acetate 8:1) to avoid oxidative oligomerisation. The isolated dipyrromethane displays a diagnostic methylene singlet at δ 4.10–4.15 ppm in ¹H NMR (400 MHz, CDCl₃). Subsequent macrocyclisation with a second portion of aldehyde under Lindsey conditions (TFA catalysis, CH₂Cl₂, aerobic oxidation) installs the porphyrin core, leaving the 4‑bromo substituent available for further decoration with solubilising chains or for anchoring onto mesoporous TiO₂ electrodes. The process-critical bottleneck is the propensity of the dipyrromethane unit to polymerise; bench‑scale procedures maintain a monomer concentration below 0.15 M and employ a magnetically driven paddle stirrer at 300 rpm to achieve rapid homogenisation. Intermediate quality control requires HPLC purity >98% (254 nm) to safeguard the ultimate porphyrin yield above 45% (based on aldehyde). Storage of the dipyrromethane at −20 °C under argon is mandatory, and silica‑based purification must be completed within 4 h of quenching to limit the formation of polar, non‑porphyrinogenic impurities.

In chemical biology, the site‑specific installation of a reporter group onto a small‑molecule probe is frequently achieved through bio‑orthogonal ligation after converting the bromine handle into an azide function. Methyl 4‑bromo‑1H-pyrrole‑2‑carboxylate is subjected to nucleophilic displacement with 3.0 eq. of sodium azide in anhydrous DMF and heated to 90 °C for 6 h. Where increased reactivity is required, addition of 0.1 eq. of copper(I) iodide accelerates the halogen exchange. The headspace is continuously swept with a gentle nitrogen stream into a dilute NaOH trap to mitigate hydrazoic acid accumulation. After cooling, the crude 4‑azido derivative is isolated by flash chromatography (silica, CH₂Cl₂/hexane 1:1) as a colourless oil and immediately characterised by IR spectroscopy; a strong azide stretch at 2110 cm⁻¹ confirms the transformation. The azide is next reacted with a dibenzocyclooctyne (DBCO)–biotin conjugate in phosphate‑buffered saline (pH 7.4) under strain‑promoted alkyne–azide cycloaddition (SPAAC) conditions, delivering the biotin‑tagged pyrrole quantitatively for subsequent live‑cell imaging or pull‑down experiments. Product identity is verified by LC‑MS (ESI+) with mass error ≤ 0.5 Da against calculated monoisotopic mass. Owing to the photolability and impact sensitivity of low‑molecular‑weight alkyl azides, all operations must be conducted behind a safety shield under yellow lighting; the neat intermediate is stored at ≤ 25 °C in amber vials not exceeding 5 g capacity per container.

Palladium Scavenger Screening and Kinetics Shape Post‑Reaction Purification

In fine‑chemical manufacturing, homogeneous palladium remaining after a cross‑coupling step must be removed to meet regulatory elemental impurity thresholds. For a reaction stream containing the biaryl derivative of methyl 4‑bromo‑1H-pyrrole‑2‑carboxylate produced via Suzuki coupling, three scavenging technologies were compared head‑to‑head: (a) Darco KB‑G activated carbon at 5 wt% loading; (b) silica‑supported thiourea (Si‑TU) at 3 wt%; and (c) polystyrene‑bound triethylenetetramine (PS‑TETA) at 4 wt%. The dark toluene solution was stirred mechanically at 150 rpm while maintained at 40 °C, and aliquots were withdrawn at timed intervals for ICP‑MS determination of palladium content according to USP <233>. Kinetic profiles revealed that Si‑TU lowered the Pd concentration from 320 ppm to 4 ppm within 3 h, outperforming the other systems in both rate and final cleanliness; product adsorption onto Si‑TU was below 1% by HPLC assay. PS‑TETA required 6 h to reach 8 ppm, but product recovery declined by approximately 3% relative to the control, indicating non‑specific binding. Darco KB‑G left a residual Pd of 12 ppm and clogged the 0.2 µm PTFE membrane during terminal filtration, causing a pressure build‑up to 1.5 bar across a 47 mm disc. Based on these comparative data, the validated post‑reaction protocol implements Si‑TU scavenging for 3 h followed by filtration through a 0.2 µm PTFE cartridge, consistently delivering active pharmaceutical ingredient intermediates with palladium levels below the 10 ppm oral‑dose limit prescribed by ICH Q3D. The table below summarizes the scavenger performance matrix and the corresponding analytical endpoints.